Effects of interferon‐alpha monotherapy on hepatic drug metabolism in cancer patients.

British Journal of Clinical Pharmacology

Volumn 36, Issue 3, 1993, Pages 229-235

  Israel, BC ^a   Blouin, RA ^a   McIntyre, W ^a   Shedlofsky, SI ^a  

^a Division of Pharmacy Practice and Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOCHROME P450; HEXOBARBITAL; PHENAZONE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; HUMAN; LIVER FUNCTION; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; ANTIPYRINE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HEXOBARBITAL; HUMAN; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGE; NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THEOPHYLLINE;

EID: 0027179010     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1993.tb04222.x     Document Type: Article

References (45)

1. Recombinant tumor necrosis factor depresses cytochrome P‐450‐dependent microsomal drug metabolism in mice
2. Role of interleukin‐1 in the depression of liver drug metabolism by endotoxin
3. Interleukin‐1 (IL‐1) depresses cytochrome P‐450 levels and activities in mice
4. Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin‐1 and tumor necrosis factor: A comparison with lymphotoxin and interferon
5. Regulation of cytochrome P‐450IIC12 expression by interleukin‐1a, interleukin‐6 and dexamethasone
6. Depression of hepatic cytochrome P‐450 dependent monooxygenase systems with administered interferon inducing agents
7. Effects of three recombinant human leukocyte interferons on drug metabolism in mice
8. Effects of interferon inducing agents on hepatic cytochrome P‐450 drug metabolizing systems
9. Homogenous interferon from E. coli depresses hepatic cytochrome P‐450 and drug biotransformation
10. Effect of murine gamma‐interferon on the mouse liver and its drug metabolizing enzymes: comparison with human hybrid alpha‐interferon
11. The pharmacology and toxicology of interferons: an overview
12. Inhibition of antipyrine metabolism by interferon
13. Inhibition of theophylline metabolism by interferon
14. Effects of alpha‐interferon on theophylline pharmacokinetics and metabolism
15. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a ‘cocktail’ approach
16. Serum‐free in vitro bio‐assay for the detection of tumor necrosis factor
17. Products of hybridoma growth factor by human monocytes
18. Increased plasma IL‐6 concentrations in alcoholic hepatitis
19. Automated HPLC determination of antipyrine and its main metabolites in plasma, saliva and urine including 4,4′‐dihydroxy antipyrine
20. Characterization of antipyrine autoinduction in the rat utilizing a new microsampling technique for serial blood sample collection
21. Phenobarbital in the genetically obese Zucker rat I. Pharmacokinetics after acute and chronic administration
22. Effects of etiocholanolone induced fever on plasma antipyrine half lives and metabolic clearance
23. Depression of drug‐metabolizing activity in the human liver by interferon‐β
24. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a ‘cocktail’ approach
25. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes
26. Characterisation of theophylline metabolism by human liver microsomes: Inhibition and immunochemical studies
27. Caffeine and theophylline metabolism in newborn adult human hepatocytes; comparison with adult rat hepatocytes
28. Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon‐inducible cytochrome(s) P450 in human liver microsomes
29. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms
30. Differential effects of cimetidine on theophylline metabolic pathways
31. Characterization of human liver cytochromes P‐450 involved in theophylline metabolism
32. Assessment of enzyme induction in humans: toxicological implications
33. Metronidazole and antipyrine as probes for the study of foreign compound metabolism
34. Oxidative metabolism of hexobarbital in human liver: Relationship to polymorphic s‐mephenytoin 4‐hydroxylation
35. Expression of human liver cytochrome P450 protein with tolbutamide hydroxylase activity in Saccharomyces
36. Interferon suppresses erythromycin metabolism in rats and human subjects
37. The suppression of hepatic cytochrome P450 mRNA mediated by interferon inducer polyinosinic acid polycytidylic acid
38. Differential effects of recombinant interferon on constitutive and inducible cytochrome P450 isozymes in mouse liver
39. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer polyrI‐polyrC
40. Rat but not human interferons suppress hepatic oxidative drug metabolism in rats
41. Interferon down regulates the male specific cytochrome P450IIIA2 in rat liver
42. 1)
43. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers
44. A role for xanthine oxidase in the loss of cytochrome P450 evoked by interferon
45. Regulation of interleukin 1 production by alpha and beta interferons: Evidence for both direct and indirect enhancement